Search

Background: Social media and internet usage is undeniably high. Misinformation obtained from the internet and wrong treatment methods can cause serious problems in patients with acne vulgaris (AV). In this study, the sociodemographic data of AV patients, their frequency of using the internet as an information source, the relationship between them, and their attitudes and behaviors regarding their disease due to these programs were examined. Methods: 481 patients aged 14 and over diagnosed with AV were included in the study. It was conducted in a descriptive cross‐sectional type. Acne severity of all patients included in the study was determined using the Global Acne Grading System. Results: 78.3 percent of participants use social media to get information about AV. It was determined that men and single people used social media about their illnesses at a statistically significantly higher rate than women and married people (p = 0.004). In addition, patients aged 13–18 and high school graduates use social media as a source of information about their diseases, and this rate is statistically significantly higher (p < 0.001). Conclusion: Especially in the last decade, the use of social media tools to spread health messages has increased significantly. Because it has a chronic course and can cause cosmetic problems, AV patients may frequently resort to communication sources such as social media. Considering the possibility of social media misinforming patients, physicians should be aware that their patients with AV frequently use social media and should improve themselves in creating correct awareness on this issue. [ABSTRACT FROM AUTHOR]

This article discusses the potential efficacy of pioglitazone in treating actinic keratosis (AK), a skin condition caused by chronic UV exposure that can progress to invasive squamous cell carcinoma (SCC). The study enrolled four patients with type 2 diabetes mellitus who had not received previous treatment for AK. After 12 weeks of treatment with pioglitazone, there was a significant reduction in the severity of AK lesions. The study suggests that further research with larger sample sizes and longer follow-ups is needed to confirm these findings. [Extracted from the article]

This article discusses the potential benefits of combining glutathione and resveratrol in the treatment of melasma, a hyperpigmentation disorder that primarily affects women. Glutathione is known for its antioxidant properties and ability to inhibit melanin production, while resveratrol regulates melanocytes and inhibits tyrosinase. The article presents a case series of five melasma patients who received oral glutathione and resveratrol treatment for 12 weeks, resulting in a significant reduction in hyperpigmentation. The combination therapy was well-tolerated, with only one patient reporting a headache as an adverse event. The authors suggest that further studies are needed to confirm these findings and explore the potential of glutathione and resveratrol in treating other pigmented skin disorders. [Extracted from the article]

Malignant peripheral nerve sheath tumors (MPNSTs) are rare sarcomas associated with Schwann cells and neurofibromatosis type 1. The cutaneous subtype of MPNST is diagnosed primarily through histological findings, but immunohistochemistry is limited because of the overlap of markers with other soft tissue tumors. Treatment involves surgical excision followed by radiotherapy. Herein, we report a 37-year-old female patient who presented with a progressive, painless, cutaneous lesion in the left frontal region. Histopathological and immunohistochemical analyses revealed spindle cell neoplastic proliferation with strong S100 and SOX10 positivity, confirming the diagnosis of cutaneous malignant peripheral nerve sheath tumors (C-MPNST). The tumor was excised, and adjuvant radiotherapy at a dose of 64 Gy. Our findings provide valuable insights into the clinical and pathological characteristics, management strategies, and prognostic factors of C-MPNSTs. [ABSTRACT FROM AUTHOR]

This article discusses a case of a 60-year-old HIV-positive male patient who presented with symptoms resembling monkeypox, but was ultimately diagnosed with secondary syphilis. The patient had ulcerative lesions on his chin and a maculopapular rash on his neck and back. Laboratory tests confirmed the presence of HIV and secondary syphilis co-infection. The patient was treated with benzathine penicillin G, and the lesions improved. The article highlights the importance of considering syphilis as a potential diagnosis, as it can mimic other diseases such as monkeypox. The incidence of syphilis has been increasing, particularly among men who have sex with men. [Extracted from the article]

Background: A broad spectrum of skin diseases, including hair and nails, can be directly or indirectly triggered by COVID‐19. It is aimed to examine the type and frequency of hair and nail disorders after COVID‐19 infection. Methods: This is a multicenter study conducted on consecutive 2171 post‐COVID‐19 patients. Patients who developed hair and nail disorders and did not develop hair and nail disorders were recruited as subject and control groups. The type and frequency of hair and nail disorders were examined. Results: The rate of the previous admission in hospital due to COVID‐19 was statistically significantly more common in patients who developed hair loss after getting infected with COVID‐19 (P < 0.001). Telogen effluvium (85%) was the most common hair loss type followed by worsening of androgenetic alopecia (7%) after COVID‐19 infection. The mean stress scores during and after getting infected with COVID‐19 were 6.88 ± 2.77 and 3.64 ± 3.04, respectively, in the hair loss group and were 5.77 ± 3.18 and 2.81 ± 2.84, respectively, in the control group (P < 0.001, P < 0.001). The frequency of recurrent COVID‐19 was statistically significantly higher in men with severe androgenetic alopecia (Grades 4–7 HNS) (P = 0.012; Odds ratio: 2.931 [1.222–7.027]). The most common nail disorders were leukonychia, onycholysis, Beau's lines, onychomadesis, and onychoschisis, respectively. The symptoms of COVID‐19 were statistically significantly more common in patients having nail disorders after getting infected with COVID‐19 when compared to the control group (P < 0.05). Conclusion: The development of both nail and hair disorders after COVID‐19 seems to be related to a history of severe COVID‐19. [ABSTRACT FROM AUTHOR]

Background: Rosacea is a chronic inflammatory skin disease that has been reported to be associated with many systemic disorders including respiratory diseases. Aims: This study aims to investigate respiratory function in patients with rosacea. Patients/Methods: Patients with rosacea and age‐ and gender‐matched healthy volunteers were included in this cross‐sectional study. Spirometric pulmonary function tests including the percentage of forced vital capacity (FVC%), percentage of forced expiratory volume in one second (FEV 1%), forced expiratory flow at 25–75% of FVC (FEF 25–75%), and FEV 1/FVC ratio was assessed in both patient and controls. The potential relationship between rosacea severity and pulmonary functions was assessed. Results: A total of 120 patients with rosacea and 120 healthy controls were enrolled in the study. Compared to the controls, FEV 1%, FEV 1/FVC%, and FEF 25–75% values were significantly lower in patients with rosacea. Lower FEV 1/FVC% values were found to be associated with disease severity. FEV 1%, FEV 1/FVC%, and FEF 25–75% values were found to be more useful in differentiating the patients from healthy subjects. Conclusions: This study showed that patients with rosacea may have abnormal respiratory function compared to healthy subjects. Besides, disease severity was associated with worse respiratory functions. We believe that patients with rosacea, particularly those with additional risk factors, should be screened for respiratory disorders. [ABSTRACT FROM AUTHOR]